Ortin Global
ORTINGLOBE · Pharma > Pharmaceuticals & Drugs · MD: S Murali Krishna Murthy · Listing date: Aug. 21, 2015

Stock Price vs Company Growth
1d
3.3%
1w
1.4%
1m
13.8%
3m
2.6%
6m
14.3%
1y
11.8%
5y
14.2%
10y
3.3%
all
1.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 14.9 3.3%
13.7
21.1
Company Overview

Sales
81.9 Cr
Growth: 70.3%
Profit after Tax
0.52 Cr
Growth: -59.5%
Micro Cap
12.1 Cr
P/E: 49.6x
Industry P/E: 32.3x
Fundamentals

Sales (Cr) ₹ 81.9
Growth 70.3%
EBITDA 7.9%
P/S 0.1x
Dividend 0.0%
P/E 49.6x
Book Value ₹ 25.4
PEG Ratio 0.7x
ROE 2.4%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Sanka Venkata Ratnamma
2.37 %
Sanka Balaji Venkateswarlu
1.88 %
Sanka Murali Krishna Murthy
1.65 %
Sanka Srinivas Kumar
1.63 %
Sanka Venkata Sujatha
1.5 %
Others
Rajesh Poddar
4.69 %
Korripati Pullaiah
3.06 %
Shabbir Nazmuddin Paratha
1.75 %
Survival Technologies Private Ltd
1.24 %
Bp Equities Private Limited
1.03 %
Increase    Decrease    No change
Company Profile Detailed

Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public.
Investors (86)